These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35144425)

  • 1. Sildenafil for adult Asian patients with pulmonary arterial hypertension: a systematic review and meta-analysis.
    Shi Q; Wang Z; Yang N; Ma Y; Chen Y; Wei H; Yao H
    Ann Palliat Med; 2022 Jan; 11(1):339-351. PubMed ID: 35144425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.
    Simonneau G; Rubin LJ; Galiè N; Barst RJ; Fleming TR; Frost AE; Engel PJ; Kramer MR; Burgess G; Collings L; Cossons N; Sitbon O; Badesch DB;
    Ann Intern Med; 2008 Oct; 149(8):521-30. PubMed ID: 18936500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary vasodilator therapies in pulmonary arterial hypertension associated with CHD: a systematic review and network meta-analysis.
    Yasuhara J; Watanabe K; Watanabe A; Shirasu T; Matsuzaki Y; Watanabe H; Takagi H; Sumitomo N; Kuno T
    Cardiol Young; 2023 Nov; 33(11):2297-2311. PubMed ID: 36721907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of sildenafil treatment in pulmonary arterial hypertension: a systematic review.
    Wang RC; Jiang FM; Zheng QL; Li CT; Peng XY; He CY; Luo J; Liang ZA
    Respir Med; 2014 Mar; 108(3):531-7. PubMed ID: 24462476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension.
    Hoeper MM; Ewert R; Jansa P; Sirenko Y; Skride A; Balagtas C; Hackley S; Vogt S; Abreu P; Haughie S; Hassan T; Oudiz RJ
    Circulation; 2024 Jun; 149(25):1949-1959. PubMed ID: 38752352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sildenafil for pulmonary arterial hypertension associated with connective tissue disease.
    Badesch DB; Hill NS; Burgess G; Rubin LJ; Barst RJ; Galiè N; Simonneau G;
    J Rheumatol; 2007 Dec; 34(12):2417-22. PubMed ID: 17985403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of Sildenafil treatment in pulmonary hypertension caused by chronic obstructive pulmonary disease: A meta-analysis.
    Hao Y; Zhu Y; Mao Y; Xu J; He X; Huang S; Wang M; Qiu J
    Life Sci; 2020 Sep; 257():118001. PubMed ID: 32634428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of 1, 5, and 20 mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension: a randomized, double-blind study with open-label extension.
    Vizza CD; Sastry BK; Safdar Z; Harnisch L; Gao X; Zhang M; Lamba M; Jing ZC
    BMC Pulm Med; 2017 Feb; 17(1):44. PubMed ID: 28228114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of sildenafil therapy in pulmonary artery hypertension: a meta-analysis].
    Kuang TG; Wang J; Zhai ZG; Guo XH; Wang C
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1021-4. PubMed ID: 17672963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation.
    Chen YF; Jowett S; Barton P; Malottki K; Hyde C; Gibbs JS; Pepke-Zaba J; Fry-Smith A; Roberts J; Moore D
    Health Technol Assess; 2009 Oct; 13(49):1-320. PubMed ID: 19863849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial.
    Vizza CD; Jansa P; Teal S; Dombi T; Zhou D
    BMC Cardiovasc Disord; 2017 Sep; 17(1):239. PubMed ID: 28874133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and effect of sildenafil on treating paediatric pulmonary arterial hypertension: a meta-analysis on the randomised controlled trials.
    Zhang Q; Xu B; Lv J; Wang Z; Du J
    Cardiol Young; 2020 Dec; 30(12):1882-1889. PubMed ID: 33077013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Sildenafil Citrate on Pulmonary Arterial Systolic Pressure and Sub-maximal Exercise Capacity in Chronic Obstructive Pulmonary Disease.
    Shrestha SK; Srivastava B; Karki M; Khatri DB; Pradhan RM
    Kathmandu Univ Med J (KUMJ); 2017 Oct.-Dec.; 15(60):271-278. PubMed ID: 30580340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin for pulmonary arterial hypertension.
    Barnes H; Yeoh HL; Fothergill T; Burns A; Humbert M; Williams T
    Cochrane Database Syst Rev; 2019 May; 5(5):CD012785. PubMed ID: 31042010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.
    McLaughlin VV; Benza RL; Rubin LJ; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubenfire M; Seeger W
    J Am Coll Cardiol; 2010 May; 55(18):1915-22. PubMed ID: 20430262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Two-year follow-up of pulmonary arterial hypertension patients treated with sildenafil].
    Franchi SM; Barreto AC; Cícero C; Castro CR; Ribeiro ZV; Lopes AA
    Arq Bras Cardiol; 2010 May; 94(5):671-7. PubMed ID: 20428715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sildenafil for congenital heart diseases induced pulmonary hypertension, a meta-analysis of randomized controlled trials.
    Awad AK; Gad ER; Abdelgalil MS; Elsaeidy AS; Ahmed O; Elbadawy MA
    BMC Pediatr; 2023 Jul; 23(1):372. PubMed ID: 37474896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Efficacy and Safety of Targeted Therapies for Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Network Meta-Analysis.
    Chen Y; Li F; Luo J; Chen J; Luo P; Li J
    Can Respir J; 2021; 2021():1626971. PubMed ID: 34512819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study.
    Wilkins MR; Paul GA; Strange JW; Tunariu N; Gin-Sing W; Banya WA; Westwood MA; Stefanidis A; Ng LL; Pennell DJ; Mohiaddin RH; Nihoyannopoulos P; Gibbs JS
    Am J Respir Crit Care Med; 2005 Jun; 171(11):1292-7. PubMed ID: 15750042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
    Garg N; Sharma MK; Sinha N
    Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.